NEW YORK (GenomeWeb) – Mergers and acquisitions in the omics life science tools and molecular diagnostics industries slowed in the first half of 2017, down 14 percent from H1 2016.

According to an analysis by GenomeWeb, the first six months of the year saw the announcement of 30 deals, down from 35 completed deals in H1 2016. This brings the number of deals so far this year back down to H1 2015 levels.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.